Advanced search
Publication Cover
Future Cardiology Volume 3, 2007 - Issue 2
Submit an article Journal homepage
70
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Brain Natriuretic Peptide: Does it Play a Role in Post-Cardiac Surgery Patients?

Anil-Martin Sinhaa II. Medizinische Klinik Klinikum Coburg Ketschendorfer Straße 33Coburg96450Germany. Tel: +499561226348 Fax: +49961226349 [email protected]
,
Ole-Alexander Breithardtb Medizinische Klinik 2 Universitätsklinikum Erlangen Ulmenweg 18ErlangenDE-91054Germany. Tel: +91318535319 [email protected]
&
Johannes Brachmannc II. Medizinische Klinik Kilinkum Coburg Ketschendorfer Straße 33Coburg96450Germany. Tel: +499561226348 Fax: +49961226349 [email protected]
Pages 109-113 | Published online: 26 Feb 2007

Bibliography

  • Yasue H , YoshimuraM, SumidaHet al.: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 90, 195–203 (1994).
  • Levin ER , GardnerDG, SamsonWK: Natriuretic peptides.N. Engl. J. Med., 339, 321–328 (1998).
  • Maeda K , TsutamotoT, WadaA, HisanagaT, KinoshitaM: Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.Am. Heart J., 135, 825–832 (1998).
  • McDonagh TA , RobbSD, MortonJJet al.: Biochemical detection of left-ventricular systolic dysfunction. Lancet, 351, 9–13 (1998).
  • Wieczorek SJ , WuAH, ChristensonRet al.: A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am. Heart J., 144, 834–839 (2002).
  • Troughton RW , PriorDL, PereiraJJet al.: Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J. Am. Coll. Cardiol., 43, 416–422 (2004).
  • Maisel AS , KrishnaswamyP, NowakRMet al.: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med., 347, 161–167 (2002).
  • Redfield MM , RodehefferRJ, JacobsenSJet al.: Plasma brain natriuretic peptide concentration: impact of age and gender. J. Am. Coll. Cardiol., 40, 976–982 (2002).
  • Wang TJ , LarsonMG, LevyDet al.: Impact of obesity on plasma natriuretic peptide levels. Circulation, 109, 594–600 (2004).
  • McCullough PA , DucP, OmlandTet al.: B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am. J. Kidney Dis., 41, 571–579 (2003).
  • Pfister R , ScholzM, WielckensKet al.: Use of NT-proBNP in routine testing and comparison to BNP. Eur. J. Heart Fail., 6, 289–294 (2004).
  • Kragelund C , GronningB, KoberLet al.: N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N. Engl. J. Med., 352, 666–675 (2005).
  • Hutfless R , KazanegraR, MadaniMet al.: Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J. Am. Coll. Cardiol., 43, 1873–1879 (2004).
  • Chello M , MastrorobertoP, PerticoneFet al.: Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass. Eur. J. Cardiothor. Surg., 20, 140–146 (2001).
  • Watanabe M , EgiK, HasegawaSet al.: Significance of serum atrial and brain natriuretic peptide release after coronary artery bypass grafting. Surg. Today, 33, 671–673 (2003).
  • Wazni OM , MartinDO, MarroucheNFet al.: Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation, 110, 124–127 (2004).
  • Bergler-Klein J , KlaarU, HegerMet al.: Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation, 109, 2302–2308 (2004).
  • Eimer MJ , EkeryDL, RigolinVHet al.: Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function. Am. J. Cardiol., 94, 676–678 (2004).
  • El Gamel A , YonanNA, KeevilBet al.: Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation. Ann. Thorac. Surg., 63, 1095–1100 (1997).
  • Masters RG , DaviesRA, VeinotJP, HendryPJ, SmithSJ, de Bold AJ: Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation, 100, 287–291 (1999).
  • Claudius I , LanYT, ChangRK, WetzelGT, AlejosJ: Usefulness of B-type natriuretic peptide as a noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients.Am. J. Cardiol., 92, 1368–1370 (2003).
  • Morrison LK , HarrisonA, KrishnaswamyPet al.: Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung diseases in patients presenting with dyspnea. J. Am. Coll. Cardiol., 39, 202–209 (2002).
  • Kucher N , PrintzenG, GoldhaberSZ: Prognostic role of brain natriuretic peptide in acute pulmonary embolism.Circulation, 107, 2545–2547 (2003).
  • Wiviott SD , CannonCP, MorrowDAet al.: Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 substudy. Circulation, 109, 580–586 (2004).
  • Lemos JA , MorrowDA, BentleyJHet al.: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N. Engl. J. Med., 345, 1014–1021 (2001).
  • Richards AM , NichollsMG, EspinerEAet al.: B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation, 107, 2786–2792 (2003).
  • Mueller C , ScholerA, Laule-KilianKet al.: Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N. Engl. J. Med., 350, 647–654 (2004).
  • Sinha AM , BreithardtOA, SchmidM, StellbrinkC: Brain natriuretic peptide release in cardiac surgery patients.Thorac. Cardiovasc. Surg., 53, 138–143 (2005).
  • Troughton RW , FramptonCM, YandleTGet al.: Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet, 355, 1126–1130 (2000).
  • Tsutamoto T , WadaA, MaedaKet al.: Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J. Am. Coll. Cardiol., 37, 1228–1233 (2001).
  • Richards AM , DoughtyR, NichollsMGet al.: Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Circulation, 99, 786–792 (1999).
  • Latini R , MassonS, AnandIet al.: Effects of Valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: (Val-HeFT). Circulation, 106, 2454–2458 (2002).
  • Wang T et al. Larson MG, Levy D : Plasma natriuretic peptide levels and the risk of cardiovascular event and death. N. Engl. J. Med., 350, 655–663 (2004).
  • Colucci WS , ElkayamU, HortonDPet al.: Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N. Engl. J. Med., 343, 246–253 (2000).
  • Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF): Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA, 287, 1531–1540 (2002).
  • Gordon GR , SchumannR, RastegerHet al.: Nesiritide for treatment of perioperative low cardiac output syndromes in cardiac surgical patients: an initial experience. J. Anesth., 20, 307–311 (2006)
  • Salzberg SP , FilsoufiF, AnyanwuAet al.: High-risk mitral valve surgery: perioperative hemodynamic optimization with Nesiritide (BNP). Ann. Thorac. Surg., 80, 502–506 (2005).
  • Moazami N , DamianoRJ, BaileyMSet al.: Nesiritide (BNP) in the management of postoperative cardiac patients. Ann. Thorac. Surg., 75, 1974–1976 (2003).
  • Sackner-Bernstein JD , SkopickiHA, AaronsonKD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.Circulation, 111, 1487–1491 (2005).
  • Kristeller JL , PappsH, StahlRF: Risk of worsening renal function with nesiritide following cardiac surgery.Am. J. Health Syst. Pharm., 63, 2351–2353 (2006).
  • de Denus S , PharandC, WilliamsonDR: Brain natriuretic peptide in the management of heart failure.Chest, 125, 652–668 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.